The antipsychotic drug sertindole is a specific inhibitor of α(1A)-adrenoceptors in rat mesenteric small arteries

European Journal of Pharmacology

Volumn 336, Issue 1, 1997, Pages 29-35

  Ipsen, Merete ^a   Zhang, Youyi ^c   Dragsted, Nils ^b   Han, Chide ^c   Mulvany, Michael J ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b H LUNDBECK A S   (Denmark)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Adrenoceptor subtype; Antipsychotic; Small artery

Indexed keywords

2 [2 (4 HYDROXYPHENYL)ETHYLAMINOMETHYL]TETRALONE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; NEUROLEPTIC AGENT; PHENYLEPHRINE; RECEPTOR SUBTYPE; SERTINDOLE;

ANIMAL TISSUE; AORTA; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CELL; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIPSYCHOTIC AGENTS; AORTA; CELL LINE; IMIDAZOLES; INDOLES; MALE; MESENTERIC ARTERIES; PHENYLEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0030734044     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01242-9     Document Type: Article

References (35)

1. Buckner S.A., Oheim K.W., Morse P.A., Knepper S.M., Hancock A.A. Alpha 1-adrenoceptor-induced contractility in rat aorta is mediated by the alpha 1D subtype. Eur. J. Pharmacol. 297:1996;241-248.
2. Burt R.P., Chapple C.R., Marshall I. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen. Br. J. Pharmacol. 115:1995;467-475.
3. Chen H., Fetscher C., Schafers R.F., Wambach G., Philipp T., Michel M.C. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;314-323.
4. Cheng Y., Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor. Biochem. Pharmacol. 22:1973;3099-3108.
5. Curtis V.A., Kerwin R.W. A risk-benefit assessment of risperidone in schizophrenia. Drug Saf. 12:1995;139-145.
6. Deng X.F., Chemtob S., Varma D.R. Characterization of alpha-1D-adrenoceptor subtype in rat myocardium, rat and other tissues. Br. J. Pharmacol. 119:1996;269-276.
7. Dunn C.J., Fitton A. Sertindole. Cns Drugs. 5:1996;224-230.
8. Eltze M. In functional experiments, risperidone is selective, not for the B, but for the A subtype of alpha 1-receptors. Eur. J. Pharmacol. 295:1996;69-73.
9. Engel G., Hoyer D. BE 2254, a new high affinity radioligand for alpha 1-adrenoceptors. Eur. J. Pharmacol. 73:1981;221-224.
10. Fenger Gron J., Mulvany M.J., Christensen K.L. Mesenteric blood pressure profile of conscious, freely moving rats. J. Physiol. Lond. 488:1995;753-760.
11. Furukawa K., Rosario D.J., Smith D.J., Chapple C.R., Uchiyama T., Chess-Williams R. Alpha 1A-adrenoceptor-mediated contractile responses of the. Br. J. Pharmacol. 116:1995;1605-1610.
12. Graham R.M., Perez D.M., Hwa J., Piascik M.T. Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ. Res. 78:1996;737-749.
13. Hyttel J., Nielsen J.B., Nowak G. The acute effect of sertindole on brain 5-HT-2, D-2 and alpha-1 receptors (ex vivo radioreceptor binding studies). J. Neural. Transm. 89:1992;61-69.
14. Ipsen, M., 1995. Characteristics of sertindole concerning alpha-1-adrenoceptors and tolerance; Alpha-1-subtype specificity of small arteries. Aarhus University, Aarhus (masters thesis).
15. Ipsen M., Dragsted N., Mulvany M.J. Functional distribution of alpha-1 adrenoceptor subtypes in mesenteric small arteries of the rat. Pharmacol. Res. 31 (Suppl.):1997;192. Abstract.
16. Kenakin, T., 1993. Pharmacologic Analysis of Drug-Receptor Interaction. Raven, New York, p. 341.
17. Kenny B.A., Chalmers D.H., Philpott P.C., Naylor A.M. Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 115:1995;981-986.
18. Kong J.Q., Taylor D.A., Fleming W.W. Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat. J. Pharmacol Exp. Ther. 268:1994;1153-1159.
19. Leech C.J., Faber J.E. Different alpha-adrenoceptor subtypes mediate constriction of arterioles and venules. Am. J. Physiol. 270:1996;H710-H722.
20. Marshall I., Burt R.P., Chapple C.R. Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype. Br. J. Pharmacol. 115:1995;781-786.
21. Meier, E., Hyttel, J., 1992. Identification and Characterization of Binding Sites for 3-H Sertindole. 22nd Annual Meeting. Society for Neuroscience (Abstract).
22. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41:1977;19-26.
23. Nyborg N.C.B., Bevan J.A. Increased alpha-adrenergic receptor affinity in resistance vessels from hypertensive rats. Hypertension. 11:1988;635-638.
24. Olesen O.V., Thomsen K., Jensen P.N., Wulff C.H., Rasmussen N.A., Refshammer C., Sorensen J., Bysted M., Christensen J., Rosenberg R. Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: A cross-sectional study. Psychopharmacology Berl. 117:1995;371-378.
25. Piascik P., Alexander S. Update on biotech information sources. Am. Pharm. NS35:1995;8-9.
26. Saussy D.L.J., Goetz A.S., Queen K.L., King H.K., Lutz M.W., Rimele T.J. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: Further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. J. Pharmacol. Exp. Ther. 278:1996;136-144.
27. Sánchez C., Arnt J., Dragsted N., Hyttel J., Lemb¢l H.L., Meier E., Perregaard J., Skarsfeldt T. Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound. Drug Dev. Res. 22:1991;239-250.
28. Skarsfeldt T., Perregaard J. Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat. Eur. J. Pharmacol. 182:1990;613-614.
29. Sleight A.J., Koek W., Bigg D.C. Binding of antipsychotic drugs for alpha-1A- and alpha-1B-adrenoceptors: Risperidone is selective for alpha-1B-adrenoceptors. Eur. J. Pharmacol. 238:1993;407-410.
30. Teng C.M., Guh J.H., Ko F.N. Functional identification of alpha 1-adrenoceptor subtypes in. Eur. J. Pharmacol. 265:1994;61-66.
31. Testa R., Guarneri L., Poggesi E., Simonazzi I., Taddei C., Leonardi A. Mediation of noradrenaline-induced contractions of rat aorta by the alpha 1B-adrenoceptor subtype. Br. J. Pharmacol. 114:1995;745-750.
32. Van der Graaf P.H., Shankley N.P., Black J.W. Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta. Br. J. Pharmacol. 118:1996;299-310.
33. Van Kammen D.P., McEvoy J.P., Targum S.D., Kardatzke D., Sebree T.B. A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia. Psychopharmacology. 124:1996;168-175.
34. Vargas H.M., Zhou L., Gorman A.J. Role of vascular alpha-1 adrenoceptor subtypes in the pressor response to sympathetic nerve stimulation in the pithed rat. J. Pharmacol. Exp. Ther. 271:1994;748-754.
35. Zhu W., Zhang Y., Han C. Characterization of subtype of alpha-1-adrenoceptor mediating vasoconstriction in perfused rat hind limb. Eur. J. Pharmacol. 329:1997;55-61.